ArticleAnnals of medicine2026

Serum advanced glycation end-products as a biomarker of cumulative glycaemic burden and complications in type 2 diabetes: a pilot study.

Xiuqin Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.